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Abstract
BACE1 is a key enzyme involved in the production of amyloid ß-peptide (Aß) in Alzheimer’s disease (AD) brains. Normally, its
expression is constitutively inhibited due to the presence of the 59untranslated region (59UTR) in the BACE1 promoter.
BACE1 expression is activated by phosphorylation of the eukaryotic initiation factor (eIF)2-alpha, which reverses the
inhibitory effect exerted by BACE1 59UTR. There are four kinases associated with different types of stress that could
phosphorylate eIF2-alpha. Here we focus on the double-stranded (ds) RNA-activated protein kinase (PKR). PKR is activated
during viral infection, including that of herpes simplex virus type 1 (HSV1), a virus suggested to be implicated in the
development of AD, acting when present in brains of carriers of the type 4 allele of the apolipoprotein E gene. HSV1 is a
dsDNA virus but it has genes on both strands of the genome, and from these genes complementary RNA molecules are
transcribed. These could activate BACE1 expression by the PKR pathway. Here we demonstrate in HSV1-infected
neuroblastoma cells, and in peripheral nervous tissue from HSV1-infected mice, that HSV1 activates PKR. Cloning BACE1
59UTR upstream of a luciferase (luc) gene confirmed its inhibitory effect, which can be prevented by salubrinal, an inhibitor
of the eIF2-alpha phosphatase PP1c. Treatment with the dsRNA analog poly (I:C) mimicked the stimulatory effect exerted by
salubrinal over BACE1 translation in the 59UTR-luc construct and increased Aß production in HEK-APPsw cells. Summarizing,
our data suggest that PKR activated in brain by HSV1 could play an important role in the development of AD.
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Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder that
affects 18 million people worldwide. Sufferers experience severe
memory deficits and cognitive decline, and their brains are
characterized by two pathological features – neurofibrillary tangles
and senile plaques. The former consist mainly of abnormally
phosphorylated forms of the microtubule-associated protein tau,
and the latter of amyloid ß-protein (Aß) [1], a peptide generated
by the enzymatic cleavage of an integral membrane glycoprotein
called amyloid precursor protein (APP). One of the enzymes
involved in APP cleavage is BACE1 (ß-site APP Cleaving Enzyme)
[2,3,4,5,6], a single pass transmembrane peptidase belonging to
the aspartyl protease family [7]. BACE1 expression is elevated in
AD patients but the causes are unknown [8,9,10]. Interestingly,
BACE1 protein levels are elevated in AD brains whereas BACE1
mRNA levels remain unaltered [9,10,8]. Furthermore, despite the
fact that stimuli such as oxidative stress [11,12] or hypoxia [13,14]
activate BACE1 transcription, upregulating BACE1 mRNA levels,
BACE1 translation is basally repressed by its 59untranslated region
(59UTR) [15,16,17,18]. The 59UTR of BACE1 is 470 nucleotides
long, rich in GC (,70%) and it contains four upstream initiation
codons (uAUGs). All four uAUGs, but especially the second one,
are responsible for the translational arrest that the 59UTR exerts
over the BACE1 open reading frame (ORF) [16].
The eukaryotic initiation factor 2-alpha (eIF2-alpha) is a GTP-
binding protein that catalyses the loading of the first met-tRNA
into the ribosome to initiate protein translation [19]. When eIF2-
alpha is phosphorylated at Ser51, translation initiation is arrested,
a scenario required in the event of cellular compromise such as
glucose deprivation, ER stress or viral infection [20]. However,
there is a specific subset of mRNAs whose translation is activated
in response to eIF2-alpha phosphorylation [21,22]. A recent study
shows that BACE1 belongs to this subset of mRNAs, demonstrat-
ing that eIF2-alpha phosphorylation activates BACE1 translation
[23]. Consequently, factors that promote phosphorylation of
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leading to an increase in cleavage of APP and Ab accumulation.
There are four kinases that are capable of phosphorylating eIF2a
at Ser51: double-stranded RNA-activated protein kinase (PKR),
PKR-like ER-localized eIF2a kinase (PERK), heme-regulated
inhibitor kinase (HRI; present in erythrocytes) and general control
non-derepressible 2 kinase (GCN2; activated by amino acid
deprivation) [24]. PKR has an N-terminal domain that behaves
as a molecular sensor for any double stranded RNA (dsRNA)
formed during the replication of viral genomes [25]. Molecular
recognition of dsRNA at the PKR N-terminal domain induces its
autophosphorylation at multiple sites but especially at Thr451 and
Thr446, the former being critical for the kinase activity [26],
catalysing eIF2-alpha phosphorylation at Ser51. Therefore, PKR is
a defensive viral sensor that shuts off global protein synthesis to
prevent viral protein replication within the host cell [27]. However,
this defensive cellular mechanism might have a negative side-effect,
as BACE1 translation is activated in response to eIF2-alpha
phosphorylation [23], causing breakdown of APP to Ab. Thus
PKR activation might be an important factor in AD, and in fact, a
potentially functional variation of EIF2AK2 gene (the gene coding
for PKR) has been associated with AD [28] and activated PKR has
been found in the brains of AD sufferers [29].
Many viruses cause PKR activation but only one of these has
been consistently linked to AD – herpes simplex virus type 1
(HSV1). HSV1 is a neurotropic virus that infects most humans,
usually during infancy. Once a person is infected, the virus persists
lifelong in the peripheral nervous system. HSV1 is the cause of
several diseases including herpes labialis, genital herpes and a
severe, but rare, brain disorder called herpes simplex encephalitis
(HSE). HSV1 was originally proposed as a factor in AD because
the brain regions that are affected in HSE are the same as those in
AD – the frontal and temporal cortices [30]. Subsequent work has
shown that HSV1 is present in the brains of elderly humans [31]
and that it confers risk of AD in subjects who possess a specific
genetic factor: the type 4 allele of the apolipoprotein E gene
(APOE-e4) [32]. Recently, the virus was shown to cause Ab
accumulation [33] and abnormal tau phosphorylation [34], and to
increase the levels of the associated enzymes, including BACE1
[33]. Also, HSV1 DNA was found to be very specifically
associated with amyloid plaques in AD brains [34].
The mechanism by which HSV1 induces BACE1 expression is
unknown. However, it is a plausible hypothesis that PKR
activation and subsequent eIF2-alpha phosphorylation activate
BACE1 translation in HSV1-infected neurons. In the present work
we investigated this possibility. Firstly, we present evidence that
HSV1 infection activates PKR in neuroblastoma cells and in
dorsal root ganglion (DRG) from HSV1-infected mice. To provide
a mechanistic insight into the way PKR induces BACE1
translation, we cloned BACE1 59UTR and inserted it upstream
of a luciferase (luc) gene. As expected, BACE1 59UTR repressed
the reporter signal. Salubrinal (Sal003), an inhibitor of the eIF2-
alpha phosphatase PP1c, de-repressed the reporter signal in the
59UTR-luc construct, demonstrating a positive effect exerted by
eIF2-alpha phosphorylation over the 59UTR-luc construct.
Synthetic polyinosinic–polycytidylic acid (poly [I:C]), which is an
analog of dsRNA [35,36], resulted in in vitro PKR activation and
produced a recovery in 59UTR-luc reporter signal comparable to
that obtained by Sal003. Furthermore, a specific PKR inhibitor
[37] reversed the rise in reporter signal induced by poly (I:C),
thereby indicating that PKR triggers BACE1 translation.
Previous studies reported PKR activation in neurons from AD
brains [38,29]. We confirmed these findings in brain sections that
were previously tested for HSV1 infection [34]. Interestingly,
activated PKR was only present in AD neurones although HSV1
DNA was present in the tissue from a non-demented subject as well.
Materials and Methods
Ethics statement
The procedure to dissect mouse embryos followed the E.U.
guidelines for animal experimentation and it was approved by the
Ethics Committee for Animal Experimentation of the Institut
Municipal d’Investigacions Me `diques (IMIM)-Universitat Pompeu
Fabra (UPF) (Approval ID: JMC-07-1001P1-PML). Finally,
human brain sample study was carried out with the ethical
permission obtained from Tameside & Glossop Local Research
Ethics Committee (UK; Approval ID: 05/Q1402/37). Written
informed consent was obtained for all study participants.
Reagents
Synthetic dsRNA polyinosinic:polycytidylic acid (poly (I:C))
(Sigma) was purchased from Sigma-Aldrich (St. Louis, MO, USA).
An imidazolo-oxindole compound that acts as a potent ATP-
binding site directed inhibitor of PKR [37] was purchased from
Calbiochem (San Diego, CA, USA). All media and additives for
cell culture were purchased from Gibco (Carlsbad, CA, USA).
Cell cultures
Human neuroblastoma cells (SH-SY5Y) were grown with F-12
(Ham) supplemented with 15% fetal bovine serum (FBS) and
antibiotics (100 units/mL penicillin and 100 mg/mL streptomy-
cin). HEK cells overexpressing the Swedish mutation of APP
(HEK-APPsw) (kindly provided by Dr. B. de Strooper; K.U.
Leuven, Belgium), PERK knock-out mouse embryonic fibroblast
(MEF) cells (kindly provided by Dr. D. Cavener; Pennsylvania
State University, USA) and HeLa cells were grown with
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% FBS and antibiotics (100 units/mL penicillin and
100 mg/mL streptomycin). Cells were incubated at 37uCi na
humidified atmosphere of 5% CO2.
Mouse embryo hippocampal cell cultures
Hippocampal cells were isolated from 18-day-old OF1 mouse
embryos. Hippocampi were aseptically dissected and trypsinized.
Cells were seeded in phenol-red-free DMEM plus 10% horse
serum on to 1% poly-L-Lysine coated coverslips (5610
4 cells/
cover). After 120 min, medium was removed and neurobasal
medium was added containing 1% B27 supplement (Gibco BRL)
plus antibiotics. Cultured hippocampal cells were used for the
experiments on day 7 when they were considered to be mature
neurons [40].
Human brain samples
Serial temporal lobe sections from an AD patient and an age-
matched control were kindly provided by the South West
Dementia Brain Bank, Bristol, UK. The individuals analysed
were a 78 years old control female carrying the APOE genotype
E3E3, and a 75 years old AD female carrying the APOE genotype
E3E4. A previous study [34] carried out on sequential sections of
the same samples revealed that HSV1 DNA was present in both.
Mouse dorsal ganglion samples
Sections of DRG from HSV1-infected mice werekindly provided
by Dr Stacey Efstathiou, University of Cambridge, UK. Five 8–9
week old BALB/c mice were infected with 10
6 plaque forming units
(pfu) of HSV1 strain SC16 by ear scarification in the left ear pinna.
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and CIV cervical DRG were pooled from the five mice. The
contralateral sensory ganglia from the same animals were used as
control, uninfected ganglia.
Protein identification by Western Blot
Cells were lysed on ice with a solution containing 1 M Tris-
HCl, 1% Nonidet P-40, 150 mM NaCl, 5 mM EDTA, 1 mM
sodium orthovanadate, 1 mM dithiotreitol, pH 7.4 and a protease
inhibitor cocktail (Roche, Basel, Switzerland). Protein concentra-
tion was determined by Bio-Rad protein assay. Protein samples
were electrophoretically resolved within 10% Tris-HCl gels run at
150 V for 1 h and afterwards transferred to nitrocellulose
membranes using iBlot Gel Transfer System (Invitrogen).
Membranes were blocked in Tween 20-Tris buffer solution
(TTBS: 0.1% v/v Tween 20, 100 mM Tris-HCl, 150 mM NaCl,
pH 7.5), containing 5% milk, and incubated overnight at 4uC with
1:500 rabbit anti-PKR (Abcam), 1:1000 rabbit anti-phospho-PKR
(Thr446; p-PKR) (Abcam), 1:500 rabbit anti phospho-eIF2-alpha
Ser51; p-eIF2-alpha) (Cell signalling), 1:1000 rabbit anti-BACE1
(Chemicon International), 1:1000 mouse anti-eIF2-alpha (Cell
signalling), 1:1000 mouse anti-6E10 (Covance; Atom), 1:1000
mouse anti-APP (N-terminal) (Oncogene; Calbiochem), 1:1000
rabbit anti-cleaved Notch 1 (Val1744) (Cell signalling) and 1:7000
mouse anti-tubulin (Sigma), respectively. Primary antibodies (Abs)
were diluted either in 5% skimmed milk-TTBS (anti-PKR, anti-p-
PKR, anti-BACE1, anti-6E10, anti-APP and anti-tubulin) or in
5% bovine serum albumin in TTBS (anti-p-eIF2-alpha, anti-eIF2-
alpha and anti-Notch). Peroxidase-conjugated donkey anti-rabbit
and anti-mouse (Amersham Bioscience, Buckinghamshire, U.K.)
were used as secondary Abs at 1:5000 for 1 h at room temperature
(RT). Bands were visualized with Super Signal (Pierce, Rockford,
IL, USA) and Amersham Bioscience Hyperfilm ECL kit.
Infection of SH-SY5Y cells with HSV1
HSV1 (strain SC16) stocks were prepared as described
previously [41]. SH-SY5Y cells were seeded at a concentration
of 10.74 million cells per flask (T75) and incubated overnight.
Prior to infection, growth medium was discarded and cells were
then washed briefly with 10 mL of PBS at 37uC. HSV1 was added
to 1 mL of 0.5% FBS supplemented growth medium at 3 pfu/cell.
During the 1 h of incubation, the HSV1-inoculated medium
was gently distributed homogeneously on the flask surface. This
procedure was repeated four times, every 15 min. Afterwards, the
inoculated medium was removed, and 10 mL of fresh growth
medium plus 0.5% FBS was added, followed by incubation for
24 h. For luciferase assays of BACE1 59UTR, cells could not be
infected with HSV1, as infected cells do not survive long enough
for transfection procedures to be performed. For that reason, we
used poly (I:C) as an accepted model for viral infection [35,36,42].
Poly (I:C) treatment in PERK knock-out fibroblasts
MEFs PERK
2/2 were seeded in 6-well plates and grown in
normal growth medium (DMEM+10% FBS+Antibiotics) until
they reached a confluence of ,80%. To stimulate the cells with
poly (I:C) the growing medium was replaced for growth medium
containing 5 mg/mL poly (I:C). Control cells were not exposed to
poly (I:C) and they were left in growth medium during the
experiment. Cells were treated with poly (I:C) for 3 h or 6 h. Cells
were washed twice in PBS, lysed and proteins were extracted.
Poly (I:C) treatments to study gamma-secretase activity
HEK-APPsw were seeded in 6-well plates and grown in nor-
mal growth medium (DMEM+10% FBS+Antibiotics) until they
reached a confluence of ,80%. The cells were incubated with
10 mM of DAPT (gamma-secretase inhibitor) for 24 h. Then cells
were treated with 5 mg/mL poly (I:C) for 3 h. Cells were washed
twice in PBS, lysed and proteins were extracted. C99, total APP,
Notch Intracellular C-Domain (NICD) and soluble APPalpha
(sAPPalpha) were studied by western blot as indicated above.
Immunocytochemistry, immunohistochemstry and
immunofluorescence
For immunocytochemistry, SH-SY5Y cells were grown on
aminopropylethoxysilane (APES)-coated glass slides and infected
with HSV1 (one pfu/cell). Slides were fixed for 10 min in 4%
formalin and 10% acetic acid in PBS, washed and left overnight in
70% ethanol. Afterwards, slides were washed twice, for 5 min, in
Tris-Buffer saline (TBS) and then rinsed in 20% (v/v) acetic acid
for 45 s to inhibit endogenous alkaline phosphatase activity. Next,
slides were washed twice in TBS containing 0.025% (v/v) Triton
X-100 and blocked in 10% (w/v) skimmed milk in TBS for 1 h at
RT on a shaker. After two further washes in TBS, primary Abs
were applied in 1% (w/v) skimmed milk in TBS and incubated
overnight in an hydration chamber at the following dilutions:
1:100 rabbit anti-p-eIF2-alpha Ser51) (Cell signalling), 1:100
rabbit anti-p-PKR (Thr446; Abcam) and 1:100 rabbit anti-
BACE1 (Abcam). Slides were rinsed in TBS containing 0.025%
Triton X-100 and treated for 2 h with a biotinylated secondary Ab
(Abcam) diluted in TBS plus 1% skimmed milk. Slides were again
washed twice in TBS and then treated with streptavidin-alkaline
phosphatase conjugate (Sigma) for 30 min. After two further
washes in TBS, substrate (5-bromo-4-chloro-3-indolyl phosphate/
nitro blue tetrazolium) was added and slides incubated for 30–
120 min before rinsing, mounting and UV curing.
For immunohistochemistry, human brain temporal lobe
sections and mouse DRG sections were dehydrated by treating
successively with 70%, 90% and absolute ethanol, dewaxed in
100% xylene and rehydrated by using the ethanol series in reverse.
Next, in order to expose epitopes, slides were rinsed three times in
PBS for five minutes per wash, placed in an acidic buffer (sodium
citrate 10 mM, pH 6) and autoclaved for one cycle in a Prestige
Medical. Afterwards, slides were rinsed 3 times in TBS and the
procedure continued as described above from the blocking of
endogenous alkaline phosphatase activity step.
For immunofluorescence, hippocampal primary cultures were
fixed with 4% paraformaldehyde (PFA) after treatment with poly
(I:C) at a final concentration of 5 mg/mL for 3 and 6 h. Afterwards,
cells were permeabilized with 0.1% Triton X-100 and subsequently
incubated for 2 h at RT in a hydration chamber with 1:100 rabbit
anti BACE1 Ab (Chemicon International), followed by incubation
with1:700 Alexa Fluor 488 goat anti-rabbit polyclonal Ab for 1 h at
RT. Finally, nuclei were stained with TO-PRO 3 iodide (Sigma).
Coverslips were mounted and digital images were taken with a
Leica TCS SP confocal microscope and analysed with Leica
confocal software (Heidelberg, Germany).
For immunofluorescence of brain temporal lobe sections, the
samples were dewaxed and subjected to an epitope exposure
procedure as previously described. Then, sections were blocked in
1% skimmed milk-TBS for 1 h at RT. Both primary Abs, rabbit
phospho-PKR(T446)(Abcam) and mouse BACE1 (Millipore), were
incubated simultaneously in a solution of 1% skimmed milk-TBS
at a dilution of 1:50. Primary Abs were incubated overnight in a
humidified chamber at 4uC. Then, slides were washed thrice in
PBS-Triton (0,025%) and two fluorescent secondary Abs (rabbit
Alexa-488 and mouse Alexa-555) were incubated in the dark for
1 h at a dilution of 1:700. Afterwards, slides were washed and
incubated for 10 min with a solution of TO-PRO3 iodide (diluted
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rinsed in distilled water, coverslips were mounted in mowiol and
examined by confocal microscopy.
Cloning of BACE1 59-untranslated region
Total RNA was extracted from SH-SY5Y cells, and one-step
RT-PCR was carried out using a kit (Qiagen) with primers
designed to amplify BACE1 59UTR: 59-GAAGCTTACAAG-
TCTTTCCGCCTCCCC-39,5 9-GAAGCTTGGTGGGCCCC-
GGCCTTC-39. PCR product, a single band matching the
molecular weight of BACE1 59UTR (,500 nt), was isolated and
purified from an agarose gel using the Ilustra
TM GFX
TM PCR
DNA and Gel Band Purification kit (GE Healthcare) and stored at
220uC for further uses. The 59UTR DNA fragment was then
inserted into the HindIII site of a modified pGL4.10[luc2]vector
from Promega containing the CMV promoter cloned at BglII and
HindIII sites).
Transient DNA transfection of HeLa cells and Luciferase
assay
HeLa cells were seeded in 96-well plates at a density of 9000 cells
p e rw e l la n dg ro w nfo r1 2hw i t hD M EMp l u s1 0 %F B S .A f t e r w a r d s ,
a total of 250 ng of DNA was transfected into each well, adjusting to
the following conditions: 250 ng of pcDNA3 plasmid as blanks, 25 ng
of Renilla+25 ng of CMV-Luciferase Vector+200 ng of pcDNA3
as controls, and finally 25 ng of Renilla+25 ng of BACE1-59UTR
CMV-Luciferase construct+200 ng of pcDNA3 as test samples. Cells
were transfected using JetPEI transfection reagent (PolyPlus) for 2 h.
Afterwards, medium was changed and cells were incubated for 10 h
toallowsufficient geneexpression.Then,thewellswerepreincubated
with PKR inhibitor (Calbiochem) in DMEM supplemented with
10% FBS at a final concentration of 0.3 mM for 1 h. Next, medium
containing PKR inhibitor was withdrawn, cells were washed once
with PBS and replaced with DMEM plus 1% FBS, with or without
poly (I:C) at a final concentration of 5 mg/mL for 3 h. Luciferase and
Renila activities were measured by using the Dual-Glo
TM Luciferase
Assay System (Promega) following the manufacturer’s instructions,
and luminescence was read using a luminometer (Fluostar OPTIMA,
BMG labtech).
Aß measurement
HEK-APPsw cells were grown and the growth medium was
replaced for experimental medium: phenol-red free DMEM
containing 4.5 g/L D-glucose, L-glutamine, HEPES (25 mM),
antibiotics (100 units/mL penicillin and 10
26 mg/mL streptomy-
cin) and supplemented with 0.2% FBS. Cells were treated with
poly (I:C) or untreated (controls). 800 mL of medium was collected
in each experimental condition after 3 hr, and centrifuged at
Figure 1. HSV1 infection activates PKR. SH-SY5Y cells were infected with HSV1 (1 pfu/cell, 24 h) or were not infected (controls).
Immunocytochemistry analysis was carried with the following Abs: anti-p-PKR, anti-p-eIF2-alpha and anti-BACE1 (A). Protein extracts of SH-SY5Y cells
infected with HSV1 (3 pfu/cell, 24 h) and uninfected cells (controls) were analysed by Western blotting using the following Abs: anti-BACE1, anti-p-
PKR, anti-PKR, anti-p-eIF2-alpha, anti- eIF2-alpha and anti-tubulin. Bands were quantified by densitometric analysis. Results are expressed as the mean
6 SEM of 3–4 independent experiments. * p,0.05, ** p,0.01, *** p,0.0005 by Student’s t test (B). Sections from mouse dorsal ganglion root (DRG)
were obtained from HSV1-infected mice. Contralateral uninfected ganglia were used as controls. Immunohistochemistry analysis was carried out to
detect p-PKR (C).
doi:10.1371/journal.pone.0021456.g001
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sandwich ELISA kits containing two highly specific Abs for
detection of the Aß peptides were used following manufacturer’s
instructions to measure human Aß .(1–40) and (1–42) (IBL Codes
27714 and 27712 respectively). Briefly, samples were added to
ELISA plates pre-coated with anti-human Aß .(35–40) mouse IgG
affinity purified monoclonal Ab or anti-human Aß .(38–42) rabbit
IgG affinity purified Ab. After overnight incubation and washing,
labelled Ab solution (horseradish peroxidase-conjugated anti-
human Aß . (N) rabbit IgG affinity purified Ab or horseradish
peroxidase-conjugated anti-human Aß . (N) rabbit IgG Fab affinity
purified) was added for 1 h at RT and then washed. The
chromagen (tetramethyl benzidine solution) was added and
incubated for 30 min. The absorbance at 450 nm was determined
for each sample.
Cell viability assay
HeLa cells were seeded in 96-well plates in serum- and phenol
red-free medium at a density of 1610
3 cells/100 mL/well. Cells
were treated with the PKR inhibitor (Calbiochem) at a con-
centration of 0.3 mM during 1 h. Alternatively, cells were
preincubated with the PKR inhibitor in the previously mentioned
conditions of time and concentration and subsequently treated
with poly (I:C) (Sigma) at a final concentration of 5 mg/mL.
Figure 2. Poly (I:C) induces PKR activation, upregulates BACE1 and promotes Aß production. The viral dsRNA analog
polyinosinic:polycytidylic acid [poly (I:C)] activates PKR in MEF PERK
2/2 cells. Protein extracts obtained after 3 and 6 h of poly (I:C) treatment
were analysed by Western blotting using anti-BACE1, anti-phospho-PKR(T446), anti-PKR, anti-p-eIF2-alpha, anti-eIF2-alpha and anti-tubulin Abs.
Bands were quantified by densitometric analysis. Results are expressed as the mean 6 SEM of 3 independent experiments. * p,0.05 by Student’s t
test (A). Mature hippocampal neurons were challenged with poly (I:C) for 3 h and analysed by immunofluorescence to detect BACE1 expression levels
(red staining). BACE1 expression in neurites after 6 h of treatment (green staining) is shown in the insets in the transmitted light images (B). Poly (I:C)
triggers Aß1–40 and Aß1–42 production in HEK-APPsw cells. HEK-APPsw cells were challenged with poly (I:C) at a concentration of 5 mg/mL. Then after
3 h and 6 h the media were collected and Aß1–40 and Aß1–42 levels were determined. Data are mean 6 SEM of 5–12 independent experiments.
*p,0.05 by Student’s t test (C). Study of gamma-secretase activity in HEK-APPsw treated with poly (I:C) at 3 h. Ratio of C99/total APP, NICD and ratio
of sAPP-alpha/total APP were studied in protein extracts analyzed by Western Blotting. Bands were quantified by densitometric analysis. Y axis:
arbitrary units. Results are expressed as the mean 6 SEM of 3 independent experiments. * p,0.05 by Student’s t test (D).
doi:10.1371/journal.pone.0021456.g002
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incubation time.
Cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) reduction. Briefly, 11 mLo f
MTT stock solution (5 mg/mL) were added and after 2 h the
reaction was stopped with 120 mL of DMSO. MTT reduction was
determined in a spectrophotometer at 540 and 650 nm. Control
cell values were taken as 100%.
Results
HSV1 infection activates PKR
Previous research has shown that infection with HSV1 leads to
activation of PKR which, in turn, causes phosphorylation of eIF2a
and consequently triggers a shut-off of global protein synthesis [43].
We confirmed this finding in neuroblastoma cells (SH-SY5Y)
infected with HSV1 for 24 h (Figs. 1A and 1B). Immunocytochem-
istry analysis showed a striking rise in PKR activation (phosphor-
ylatedatThr446)inHSV1-infectedcells(Fig.1A,upperpanels)that
was accompanied by a rise in the signal corresponding to p-eIF2-
alpha (middle panels) and BACE1 (lower panels). Western blot
analysis of HSV1-infected neuroblastoma cells revealed a promi-
nent band for activatedPKR (p-PKR) that was absent in the control
uninfectedcells(p,0.0005; Fig. 1B)even when non-phosphorylated
PKR was also present in control cells. Interestingly, non-
phosphorylated PKR levels were also raised when cells were
infected with HSV-1 (p,0.05; Fig. 1B). Western blotting confirmed
that p-eIF2-alpha levels are larger in HSV1-infected than in
uninfected cells (p,0.0005; Fig. 1B). Non-phosphorylated eIF2-
alpha was used as control demonstrating that total expression of
eIF2-alpha was not affected by the virus. To further study PKR
activation by HSV1, we analysed peripheral nervous tissue from
mice infected with HSV1 (Fig. 1C). Consistent with the results
obtained in neuroblastoma cells, DRG infected with HSV1 showed
a striking activation of PKR whereas no signal for active PKR
appeared on the contralateral uninfected DRG (Fig. 1C).
Activated PKR phosphorylates eIF2-alpha at Ser51 enhances
BACE1 translation [23]. Thus, HSV1 infection might be
Figure 3. Poly (I:C) induces BACE1 translation in a mechanism depending on PKR-catalysed eIF2-alpha phosphorylation. BACE1
59UTR fragment was inserted into the HindIII site of a luciferase reporter construct (59UTR-luc). The plasmids bear the strong cytomegalovirus
promoter (CMV), which allows sufficient reporter gene expression for luciferase determinations. HeLa cells were transfected with 59UTR-luc or empty
plasmids (named as CMV) for luciferase reporter studies (A). 59UTR-luc repressed translation in comparison with the empty 59UTR-free luciferase
construct (B). Inhibition of eIF2-alpha phosphatase PP1c by Sal003 de-repressed the reporter signal elicited by 59UTR-luc (C). Stimulation (3 h) with
poly (I:C) also de-repressed the reporter signal yielded by 59UTR-luc. This effect was abolished when cells were preincubated with a specific and
potent PKR inhibitor that acts via the PKR ATP-binding site. Data are mean 6 SEM of 3 independent experiments performed in triplicate. *p,0.05 by
Student’s t test (D). Incubation with the specific PKR inhibitor -in the presence/absence of poly (I:C)- did not result in a decrease in cell viability as
shown by an MTT assay. Data are mean 6 SEM of 3 independent experiments performed in triplicate (Inset in panel D).
doi:10.1371/journal.pone.0021456.g003
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eIF2a phosphorylation. Indeed, previous work has shown that
BACE1 is increased in HSV1-infected cells [33].
Poly (I:C) induces PKR activation, BACE1 upregulation and
Aß production in cultured cells
We used poly (I:C), a synthetic viral dsRNA [35,36,42], to
promote PKR activation in vitro. As shown in Fig. 2A, poly (I:C)
treatment (5 mg/mL) induces the active form of PKR (phosphor-
ylated at Thr446) in PERK knock-out fibroblasts (p,0.05).
Interestingly, BACE1 protein becomes rapidly upregulated in
response to the initial rise of p-PKR (Thr446) obtained after 3 h of
stimulation with poly (I:C) (p,0.05; Fig. 2A) and it is maintained
at 6 h (p,0.05; Fig. 2A). The same effect occurs in primary
hippocampal cultures, in which high expression of BACE1,
localized in the neurite network of hippocampal neurons, is
observed after 3 h (and 6 h) of incubation with poly (I:C) (Fig. 2B).
Consistently, a significant phosphorylation of eIF2-alpha was
observed after poly (I:C) treatment (p,0.05; Fig. 2A) due to PKR
activation. These results suggest that the increases in p-eIF2a and
BACE-1 we observe are not due to PERK activation.
The prominent BACE1 up regulation in response to the viral
dsRNA mimetic poly (I:C) (Figs. 2A and 2B) led us to ask whether
poly (I:C) could also trigger Aß production in vitro. We found that
poly (I:C) triggers both Aß1–40 and Aß1–42 production (Fig. 2C) in
HEK-APPsw cells. HEK-APPsw cells have a double mutation (Lys
to Asn at residue 595 plus Met to Leu at position 596), which
makes APP more prone to cleavage by BACE1, thus producing
early AD onset [44]. HEK-APPsw treated with poly (I:C) showed a
dramatic increase in Aß1–40 at 3 h and 6 h (p,0.05), which was
three- and two-fold the control value respectively (Fig. 2C). The
pattern for Aß1–42 (Fig. 2C) was similar to that obtained with
Aß1–40. Thus at 3 h and 6 h after poly (I:C) treatment, Aß1–42
increases to two-fold the control value (p,0.05).
To confirm that the effect of poly (I:C) was due to the up-
regulation of BACE1 and not due to the up-regulation of gamma-
secretase, we analyzed the activity of this complex. C99 is the C-
terminal APP fragment containing the full Aß sequence after APP
cleavage by BACE1. C99 is then cleaved by gamma-secretase to
Figure 4. Presence of activated PKR in human brain tissue. The presence of activated PKR -autophosphorylated at Thr446- was studied in
human brain sections (temporal lobe) from one non-demented control and one AD patient by immunohistochemistry (A). Colocalization of BACE1
and p-PKR(T446) in neurons from an AD patient. All brain sections analysed were positive for HSV1 infection as previously reported [39] (B).
doi:10.1371/journal.pone.0021456.g004
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APP ratio (p,0.05) when cells HEK-APPsw were treated with
poly (I:C), and even when cells were treated with an inhibitor of
gamma-secretase (DAPT; p,0.05) (Fig. 2D). Furthermore, we
studied the levels of cleaved Notch (Notch Intracellular C-Domain;
NICD), since Notch is one of the major substrates for gamma-
secretase [7]. Our results did not show any variation in NICD
production (Fig. 2D). Finally, we analyzed the levels of soluble APP-
alpha (sAPP-alpha), which is a product of the non-amyloidogenic
APP cleavage by alpha-secretases [7]. We observed a decrease of
sAPP-alpha total APP ratio (p,0.05) in cells treated with poly (I:C)
(Fig. 2D), suggesting an increase in the amyloidogenic APP cleavage
that fits with a BACE1 up-regulation.
BACE1 translation is activated by a mechanism
dependent on PKR activation and eIF2-alpha
phosphorylation
BACE1 translation is inhibited under basal conditions by its
59UTR [15,16,17,18], but this is reversed in response to eIF2-
alpha phosphorylation (ser51) [23]. We cloned BACE1 59UTR
and inserted it upstream of a reporter luciferase gene (59UTR-luc)
(Fig. 3A). We used this 59UTR-luc construct for transfection of
HeLa cells. As expected, the basal effect of BACE1 59UTR was to
repress translation (Fig. 3B). The high reporter signal obtained
with a strong cytomegalovirus promoter (CMV-luc) is reduced
about three-fold when BACE1 59UTR is inserted upstream of the
luciferase gene (59UTR-luc) without deleting the CMV promoter
(Fig. 3B). Sal003, an inhibitor of eIF2-alpha phosphatase PP1c, de-
repressed the reporter signal in 59UTR-luc constructs, indicating
that eIF2-alpha phosphorylation activates BACE1 translation,
overcoming the repressor effect imposed by its 59UTR (Fig. 3C).
Interestingly, poly (I:C) treatment resulted in the same effect as
that obtained with Sal003 (Fig. 3D), lifting the repression of the
59UTR-luc reporter signal with a detectable increase in luciferase
signal. Importantly, this increase in luciferase signal obtained with
poly (I:C) treatment was fully reversed when cells were previously
incubated with a specific imidazolo-oxindole PKR inhibitor [37]
(Fig. 3D).
A possible cytotoxic effect of the inhibitor or poly (I:C)
treatments that could affect the obtained data was disproved since
there were no changes in cell viability, as measured by MTT
reduction assay (inset Fig. 3D).
PKR activation in human brains
Previous studies have documented PKR activation in AD brains
[38,29]. To confirm these findings, we chose brain sections from
an AD patient and a non-demented individual both of whom were
infected with HSV1 [45]. Interestingly, PKR activation was only
detected in the AD brain tissue (Fig. 4A). HSV1 has its own
mechanisms to circumvent host defensive mechanisms. One of
these viral strategies consists of avoiding PKR activation by
binding dsRNA species to viral proteins [46]. However, this sys-
tem might be working deficiently in AD individuals, thereby
accounting for their striking activation of PKR, due to PKR poly-
morphisms as suggested by Bullido et al. [47]. Consistently, PKR
activation co-localizes with BACE1 expression in slides from
AD brains, as we have observed by immunofluorescence analysis
(Fig. 4B).
Discussion
In the present work we provide experimental data supporting
the proposition that HSV1 is a major risk factor for AD
[32,28,33], acting perhaps by increasing the Ab level via an
increased expression of BACE1 [33]. We suggest that the BACE1
increase occurs through activation of PKR, leading to BACE1 up-
regulation through eIF2-alpha phosphorylation-mediated de-
repression of BACE1 translation. The p-eIF2-alpha inhibition of
translation affects most mRNAs except those bearing a 59UTR
with specific features: long (.200 nucleotides), rich in GC content
(,70%) and containing upstream initiation codons; these mRNAs,
including BACE1 mRNA, will be more efficiently translated
into proteins during infection as a consequence of eIF2-alpha
phosphorylation. Therefore, the increase in BACE1 expression
characteristic of AD could be partially due to the translational
derepression of BACE1 mRNA exerted by HSV1. However, when
the translational arrest in global protein synthesis is sustained over
time, the infected cell undergoes programmed cell death
[48,49,50]. Interestingly, in recent years an involvement of PKR
in neurodegeneration including AD has been reported [51], which
proposes a proapoptotic role for activated PKR [29,38,52].
Intermittent activation of PKR during the lifetime of neurons by
transient activation of latent HSV1 could contribute to increased
APP amyloidogenic cleavage. Other causes of BACE1 activation
by eIF2a phosphorylation have been investigated. A recent study
[23] showed that cellular stress induced by glucose deprivation
leads to BACE1 translation via eIF2a phosphorylation, in an effect
Figure 5. Biochemical pathway linking HSV1 infection and AD.
Despite the viral ability to circumvent host defensive mechanisms,
including PKR activation, HSV1 activates PKR in vitro and in vivo.
Activated PKR increases eIF2-alpha phosphorylation levels, leading to
BACE1 translation de-repression, BACE1 protein up-regulation and Aß
production (left track; continuous line). In the right track (dotted line)
we present the pharmacological and biological tools that we used to
study this pathway: poly (I:C), to mimic the effect of viral dsRNA; a
specific imidazolo-oxindole compound that acts as a potent PKR
inhibitor; and a 59UTR-luc reporter construct used for the evaluation of
the translational effect exerted by the PKR-eIF2-alpha pathway over
BACE1 59UTR. Also, we have utilized the PP1c inhibitor salubrinal, which
prevents the dephosphorylation of eIF2-alpha.
doi:10.1371/journal.pone.0021456.g005
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phosphorylate eIF2a. [24]; however, this effect was mediated by
PERK and not PKR as in our studies. Indeed, we have found that
poly (I:C), a viral dsRNA analogue, is able to induce PKR
activation by phosphorylation at Thr446 [53] and, consistently, its
substrate, eIF2-alpha is phosphorylated at Ser51 [54]. This
suggests that the effects of HSV1 are not specific to this virus
and that other viruses may cause elevated BACE1 levels.
However, it should be stressed that HSV1 is uniquely able to
cause such changes as it is present in a high proportion of elderly
brains. HSV1 is present and is active in a high proportion of brains
of elderly normal subjects as well as AD patients [31,39].
However, PKR was activated only in the brain sample from the
AD patient. One possible explanation for this is that there might
be genetic variability in the PKR activation that could be related
to AD development. Recently a genetic association between
rs2254985 polymorphism within EIF2AK2 gene and the risk of AD
has been found [28]. Finally it has to be remarked that other
stressor factors can contribute to the phosphorylation of PKR in
AD patients by the activation of the NF-kß and p38MAPKinase
intracellular signalling pathways [55,56,57].
In conclusion, this study presents further evidence for considering
that HSV1 is an aetiological factor contributing to sporadic AD. We
confirmed that this neurotropic virus can activate PKR, an eIF2-
alpha kinase. Activated PKR results in BACE1 translation and
increasedAßproduction (Fig.5).Interestingly,despite the factthat a
high proportion of elderly people harbour HSV1 DNA in brain,
PKR is activated only in brains of AD patients, making this protein
a putative therapeutic target in AD. Other features of the life-cycle
of the virus and other factors such as APOE genotype might be
involved also in the differential pattern of PKR activation observed
within HSV1 infected brains.
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